X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (18) 18
humans (15) 15
male (14) 14
female (11) 11
middle aged (9) 9
aged (8) 8
chemotherapy (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
hematology (7) 7
life sciences (7) 7
lymphomas (7) 7
adult (6) 6
aged, 80 and over (6) 6
rituximab (6) 6
treatment outcome (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
clinical trials (5) 5
therapy (5) 5
cancer (4) 4
cyclophosphamide - therapeutic use (4) 4
doxorubicin - therapeutic use (4) 4
lymphoma, large b-cell, diffuse - drug therapy (4) 4
medical research (4) 4
medicine, experimental (4) 4
vincristine - therapeutic use (4) 4
[sdv.can]life sciences [q-bio]/cancer (3) 3
abridged index medicus (3) 3
adolescent (3) 3
analysis (3) 3
angioimmunoblastic t-cell lymphoma (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
bone marrow (3) 3
cyclophosphamide - administration & dosage (3) 3
cyclophosphamide - adverse effects (3) 3
diagnosis (3) 3
disease-free survival (3) 3
doxorubicin - administration & dosage (3) 3
doxorubicin - adverse effects (3) 3
epidemiology (3) 3
features (3) 3
france (3) 3
hematology, oncology and palliative medicine (3) 3
internal medicine (3) 3
lymphoma (3) 3
medicine, general & internal (3) 3
non-hodgkins-lymphoma (3) 3
oncology (3) 3
plus rituximab (3) 3
prednisone - administration & dosage (3) 3
prednisone - adverse effects (3) 3
prednisone - therapeutic use (3) 3
prognostic-factors (3) 3
research (3) 3
response criteria (3) 3
risk factors (3) 3
toxicity (3) 3
transplantation (3) 3
vincristine - administration & dosage (3) 3
vincristine - adverse effects (3) 3
[ sdv.can ] life sciences [q-bio]/cancer (2) 2
[sdv.can] life sciences [q-bio]/cancer (2) 2
adults (2) 2
age (2) 2
aged patients (2) 2
amyloidosis - diagnosis (2) 2
anthracyclines (2) 2
antibodies, monoclonal, murine-derived (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antibodies, monoclonal, murine-derived - therapeutic use (2) 2
b cells (2) 2
biomarkers (2) 2
care and treatment (2) 2
corticosteroids (2) 2
cyclophosphamide (2) 2
drug administration schedule (2) 2
efficacy (2) 2
elderly-patients (2) 2
enzymes (2) 2
expression (2) 2
free survival (2) 2
genetic aspects (2) 2
genomics (2) 2
hematopoietic stem cell transplantation (2) 2
hemic and lymphatic diseases (2) 2
human health and pathology (2) 2
immunoblastic lymphadenopathy - pathology (2) 2
immunology (2) 2
lymphoma, large b-cell, diffuse - mortality (2) 2
lymphoma, large b-cell, diffuse - pathology (2) 2
lymphoma, mantle-cell - drug therapy (2) 2
lymphoma, mantle-cell - therapy (2) 2
lymphoma, t-cell - pathology (2) 2
mathematical models (2) 2
mortality (2) 2
motivation (2) 2
mutation (2) 2
neutropenia (2) 2
patients (2) 2
prednisone (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10044, pp. 565 - 575
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2017, Volume 4, Issue 1, pp. e46 - e55
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 2009, Volume 54, Issue 5, pp. 931 - 934
Deferasirox is an innovative iron-chelating treatment. However, preliminary data have suggested that kidney toxicity may be a major issue in the management of... 
Nephrology | Deferasirox | iron | renal toxicity | Fanconi syndrome | EFFICACY | DEFEROXAMINE | COSTS | TRANSFUSIONAL IRON OVERLOAD | CHELATION-THERAPY | THALASSEMIA | ICL670 | UROLOGY & NEPHROLOGY | PATIENT | Benzoates - adverse effects | Triazoles - adverse effects | Humans | Male | Aged | Fanconi Syndrome - chemically induced | Iron Chelating Agents - adverse effects | Index Medicus
Journal Article
by Dimopoulos, Meletios A and Dimopoulos, Athanasios and Gay, Francesca and Schjesvold, Fredrik and Beksac, Meral and Hajek, Roman and Weisel, Katja Christina and Weisel, Katja and Goldschmidt, Hartmut and Maisnar, Vladimir and Moreau, Philippe and Min, Chang Ki and Pluta, Andrzej and Pluta, Agnieszka and Chng, Wee Joo and Chng, Wee-Joo and Kaiser, Martin and Zweegman, Sonja and Mateos, Maria-Victoria and Mateos, Maria Victoria and Spencer, Andrew and Iida, Shinsuke and Morgan, Gareth and Suryanarayan, Kaveri and Teng, Zhaoyang and Skacel, Tomas and Palumbo, Antonio and Dash, Ajeeta B and Gupta, Neeraj and Labotka, Richard and Rajkumar, S Vincent and Bar, Daniel and Basso, Alfredo and Fantl, Dorotea and He, Simon and Horvath, Neomi and Lee, Cindy and Lee, Jae Hoon and Rowlings, Phillip and Taylor, Kerry and Cochrane, Tara and Kwok, Fiona and Ramanathan, Sundreswran and Agis, Hermine and Zojer, Niklas and Kentos, Alain and Offner, Fritz and Van Droogenbroeck, Jan and Wu, Ka Lung and Maiolino, Angelo and Martinez, Gracia and Zanella, Karla and Capra, Marcelo and Araújo, Sérgio and Gregora, Evzen and Pour, Ludek and Scudla, Vlastimil and Spicka, Ivan and Abildgaard, Niels and Andersen, Niels and Jensen, Bo Amdi and Helleberg, Carsten and Plesner, Torben and Salomo, Morten and Svirskaite, Asta and Delarue, Richard and Blau, Igor and Schieferdecker, Aneta and Teleanu, Veronica and Munder, Markus and Röllig, Christoph and Salwender, Han-Juergen and Fuhrmann, Stephan and Duerig, Jan and Zeis, Matthias and Klein, Stefan and Reimer, Peter and Schmidt, Christian and Scheid, Christof and Mayer, Karin and Hoffmann, Martin and Sosada, Markus and Delimpasi, Sosana and Kyrtsonis, Mary-Christine and Anagnostopoulos, Achilleas and Nagy, Zsolt and Illés, Árpád and Egyed, Miklós and Borbényi, Zita and Mikala, Gabor and Dally, Najib and Horowitz, Netanel and Gutwein, Odit and Nemets, Anatoly and Vaxman, Iuliana and Shvetz, Olga and Trestman, Svetlana and Ruchlemer, Rosa and Nagler, Arnon and Tadmor, Tamar and ... and TOURMALINE-MM3 Study Grp and TOURMALINE-MM3 study group
The Lancet, ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 253 - 264
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 460 - 468
Summary Background Diffuse large B-cell lymphoma is a common cancer in elderly patients. Although treatment has been standardised in younger patients, no... 
Hematology, Oncology and Palliative Medicine | MAINTENANCE RITUXIMAB | COLONY-STIMULATING FACTOR | PROGNOSTIC-FACTORS | RESPONSE CRITERIA | ONCOLOGY | AGGRESSIVE LYMPHOMAS | MALIGNANT-LYMPHOMAS | NON-HODGKINS-LYMPHOMA | COMPREHENSIVE GERIATRIC ASSESSMENT | DETUDE-DES-LYMPHOMES | CHOP CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Prospective Studies | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Aged, 80 and over | Vincristine - administration & dosage | Female | France | Odds Ratio | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Risk Factors | Rituximab | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Analysis of Variance | Belgium | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - adverse effects | Doxorubicin - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Anthracyclines | Cyclophosphamide | Chemotherapy | Corticosteroids | Oncology, Experimental | Aged patients | Product development | Prednisone | Lymphomas | Research | Cancer | Toxicity | Albumin | Clinical trials | Multivariate analysis | Doxorubicin | Survival | Vincristine | Side effects | Motivation | Age | rituximab | B-cell lymphoma | Geriatrics | Neutropenia
Journal Article
by Larsabal, M and Ly, S and Sbidian, E and Moyal‐Barracco, M and Dauendorffer, J.‐N and Dupin, N and Richard, M.A and Chosidow, O and Beylot‐Barry, M and Abdo, Ivana and Acquitter, Marie and Breteque Mignot, Maud Ami and Amici, Jean‐Michel and Archier, Elodie and Aubin, François and Barthelemy, Hugues and Baubion, Emilie and Beneton, Nathalie and Bolac, Cécile and Bouilly, Danielle and Bourseau‐Quetier, Catherine and Brenaut, Emilie and Buzenet, Christel and Camus, Magalie and Celerier, Philippe and Chabbert, Cécile and Chamaillard, Mélanie and Charles, Sophie and Darrigade, Anne‐Sophie and Delarue, Michele‐Pillette and Depaire, Florence and Devaux, Suzanne and Do‐Pham, Giao and Duval‐Modeste, Anne‐Benedicte and Fabre, Françoise and Fauconneau, Antoine and Fite, Charlotte and Fleuret, Camille and Girard, Céline and Grande, Sophie and Guillet, Stéphanie and Hacard, Florence and Hegazy, Salama and Hosteing, Stéphanie and Jacquin, Marie‐Agnès and Jegou, Marie‐Hélène and Joly, Pascal and Jouary, Thomas and Julien, Denis and Kemula, Mathilde and Kostrzewa, Elise and Lacour, Jean‐Philippe and Legrain, Valérie and Livideanu, Cristina and Lu, Devy and Maccari, François and Magne, Françoise and Martin, Clemmie and Meunier, Laurent and Misery, Laurent and Parier, Josiane and Pelletier, Fabien and Perrussel, Marc and Petit‐Fauconneau, Antoine and Peyrot, Itzia and Plantin, Patrice and Pruvost‐Balland, Christelle and Regnier, Elodie and Reynier‐Rezzi, Judith and Salzes, Camille and Seneschal, Julien and Shollhammer, Martine and Souteyrand, Agathe and Staumont, Delphine and Toulemonde, Anne and Vanhaecke, Clelia and Vedie, Anne‐Laure and Versapuech, Julie and Vigan, Martine and Viguier, Manuelle and Villani, Axel
British Journal of Dermatology, ISSN 0007-0963, 03/2019, Volume 180, Issue 3, pp. 647 - 656
Summary Background Genital psoriasis is often under‐recognized. Objectives To assess the instantaneous prevalence of genital psoriasis and describe its... 
DEPRESSION | ERECTILE FUNCTION | INTERNATIONAL INDEX | FEMALE SEXUAL FUNCTION | VALIDATION | HOSPITAL ANXIETY | DYSFUNCTION | ARTHRITIS | PATIENTS EXPERIENCE | EPIDEMIOLOGY | DERMATOLOGY | Medicine, Experimental | Medical research | Arthritis | Psoriasis | Sexual disorders | Dermatology | Scalp | Ear canal | Quality of life
Journal Article
PLoS Computational Biology, ISSN 1553-734X, 03/2018, Volume 14, Issue 3, pp. e1005992 - 10
Journal Article
Haematologica, ISSN 0390-6078, 10/2012, Volume 97, Issue 10, pp. 1594 - 1602
Background In angioimmunoblastic T-cell lymphoma, symptoms linked to B-lymphocyte activation are common, and variable numbers of CD20(+) large B-blasts, often... 
Angioimmunoblastic t-cell lymphoma | Epstein-barr virus | Chop-r | DIAGNOSIS | angioimmunoblastic T-cell lymphoma | FOLLICULAR HELPER-CELL | PERIPHERAL-BLOOD | REARRANGEMENTS | FEATURES | PREDNISONE | POLYMERASE-CHAIN-REACTION | Epstein-Barr virus | CHOP-R | HEMATOLOGY | EXPRESSION | EPSTEIN-BARR-VIRUS | AITL | Doxorubicin - therapeutic use | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Immunoblastic Lymphadenopathy - mortality | B-Lymphocytes - virology | Female | Immunoblastic Lymphadenopathy - pathology | B-Lymphocytes - pathology | Prednisone - adverse effects | Rituximab | Immunoblastic Lymphadenopathy - drug therapy | Treatment Outcome | B-Lymphocytes - drug effects | Lymphoma, T-Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, T-Cell - pathology | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Lymphoma, T-Cell - mortality | Antibodies, Monoclonal, Murine-Derived - pharmacology | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Original and Brief Reports
Journal Article